spinofflive
a background of gclear plastic bottles with aquamarine tesselating squares and a dead blue fish caught in a plastic bag
What happens to all that plastic when it leaves your possession? (Image: Getty/The Spinoff)

ScienceDecember 5, 2024

Is New Zealand – and the world – doing enough to tackle the plastic problem?

a background of gclear plastic bottles with aquamarine tesselating squares and a dead blue fish caught in a plastic bag
What happens to all that plastic when it leaves your possession? (Image: Getty/The Spinoff)

With a rubbish heap of recent plastic headlines, Shanti Mathias explains what progress New Zealand has made – and how much further the international community has to go.

Plastic is everywhere, even when you don’t want it to be. It’s definitely in your house, covering the roads you cross thanks to car tyres shedding microplastics, and there are definitely plastic parts in whatever device you are reading this article on. 

Action to reduce microplastics in New Zealand has encountered several setbacks recently. To stay in line with EU standards, fruit stickers will continue to be made of plastic until 2028, instead of being replaced by compostable alternatives by July 2025. Local company Harraways Oats  changed its paper packaging to single-use plastic, advising concerned shoppers to dispose of the new packaging in the soft plastics bins that are at many supermarkets. “You will also have 100% confidence that your recycling is doing good with bin contents being reused to make things like plastic fenceposts for kiwi farms,” the brand wrote on social media, following an outcry at the change. Perhaps they hadn’t been reading the news that Future Post, the company that is supposed to turn soft plastic into fence posts, appears to take lots of its plastic to landfill – and, after being exposed for this practice, seems to now be accumulating plastic at its Auckland site. 

What’s being done to stop plastic proliferating? There are some initiatives under way, but progress is slow. Here’s what you need to know.

a pile of plastic waste laid on the ground
Microplastics pose a growing concern in our oceans, and now also in the air. (Photo: 5Gyres, courtesy of Oregon State University)

Does the New Zealand government have any policies to reduce how much plastic we produce? 

Yes, there are a number of initiatives in place. One is the phasing out of single-use and hard-to-recycle plastic. This began with the single-use plastic bag ban in 2019, with single-use drink stirrers and polystyrene takeaway trays banned from 2022, and plastic straws and cutlery in 2023. The third stage of the phase-out has been delayed to 2026, but is set to include all polystyrene food and beverage packaging and all PVC food and beverage packaging, although this is subject to Cabinet approval. There’s a reason these products have been picked – there are alternatives easily available – but walking into a supermarket in 2017 would have shown a lot more plastic available than there is now, so these changes have made a difference with minimal disruption to people’s lives (although making straws easy to access remains important).

Earlier this year recycling rules were standardised across all councils, including bottle lids no longer being accepted in recycling collections. This is meant to maximise the amount of waste that can be appropriately recycled, while making it easier to send non-recyclable items to landfill. 

Penny Simmonds, the minister for the environment, has said progress is ongoing on a container recycling scheme that was abandoned by Chris Hipkins’ Labour government. So there is progress – it’s just slow. 

Is the private sector doing anything about plastic? 

There are lots of companies that want to reduce the amount of plastic we produce, or use recycled products, many of which have been enthusiastically profiled by The Spinoff at one time or another. Many of these companies’ efforts are making a difference; at the same time, there are concerns about greenwashing, where companies talk about environmental benefits that may not exist to improve their reputation. 

Of projects that turn soft plastic into other materials, “They’re basically just distributing a landfill full of rubbishy plastic bags around the country,” Owen Embling, managing director of Hamilton-based plastic packaging company Convex, told The Spinoff in February. While the resulting product may look solid, the mixes of plastic additives can be unstable, and the plastic is often contaminated. Because plastic is so integrated into human and social systems, both at the consumer and business level, it can be hard to figure out who is being genuine in their efforts to use recycling or reduce plastic. 

a mock up of a house with slightly mottled plastic walls
SaveBoard cladding lines the interior of Zero Waste Bistro in New York City – one of the many companies trying to address plastic waste (Photo: Supplied; additional design: Tina Tiller)

Given the volume of plastic, is all this stuff just tinkering around the edges? What is happening at an international scale to take action on omnipresent plastic? 

It’s a good time to ask – we’ve just seen an example of how hard it is to come to an agreement about plastic, at an international plastic summit in Busan, South Korea. From November 25 to December 1, representatives of more than 200 countries met to try to thrash out an agreement to tackle plastic pollution, especially in the marine environment. The need for this treaty had been decided in 2022, with  a two-year deadline set for defining the treaty, time that has now passed without any agreement being reached. 

A bloc of more than 100 countries called for a reduction in the amount of plastic that is being produced (it’s currently on track to triple by 2050) but no one committed to a single option by the end of the summit. “New Zealand was part of two groups of member states calling for ambitious targets at the negotiations. Mexico led a coalition of 95 countries calling for plastic production reduction, which is a hugely ambitious piece of the puzzle that is desperately needed for an effective treaty,” said Trisia Farrelly, a Massey University professor and the coordinator of the Scientists’ Coalition for an Effective Plastics Treaty, who attended the negotiations in Korea, in comments to the Science Media Centre. 

Kuwait, Saudi Arabia and Russia, all major oil producers, worked to remove language from the treaty about who should pay for monitoring plastic use; insiders told the New York Times that Saudi delegates said that reducing supply of plastics “penalises industries without addressing the actual issue of plastic pollution”. 

This is in keeping with big oil companies that have tried to increase the use of plastic, especially in low-income countries. (Saudi Arabia’s state-owned oil company Saudi Aramco is the fourth biggest company in the world). Big plastic producers, like Unilever, have made public commitments to reduce plastic while fighting to continue producing single-use plastic packaging. Plastic is made from petroleum, and many oil companies see it as a way to keep making profits while fossil fuel use decreases. 

It’s depressing, but not all hope is lost. “Now that we’re seeing a majority of countries calling for high ambition and plastic production reduction, there’s hope that we’ll maintain that momentum at the next session,” Farrelly said.

‘Become a member and help us keep local, independent journalism thriving.’
Alice Neville
— Deputy editor
Keep going!
five silhouetted purple heads and shoulders with green clouds around them, against an orange "static" background
Image: Getty Images; additional design The Spinoff

OPINIONScienceOctober 30, 2024

The impact of long Covid will be huge. So why is New Zealand doing nothing about it?

five silhouetted purple heads and shoulders with green clouds around them, against an orange "static" background
Image: Getty Images; additional design The Spinoff

The cost is set to go far beyond human suffering, yet almost five years into the pandemic, not only are there still no treatments for long Covid, there aren’t even any diagnostic tools – and we don’t seem overly interested in finding them.

The jig is up. People are catching on that “mild” Covid-19 may not be so mild, and that the mysterious lingering symptoms they’ve experienced after catching the virus, such as fatigue and brain fog, may just be connected. For others, this will be the first time that they put two and two together. I hate to be the bearer of bad news, but strap in for what comes next.

Recently, RNZ ran a piece outlining the estimated $2bn per year economic cost of long Covid in New Zealand and signalling that further research would be needed to determine a more precise figure. The average reader would assume that this research is under way or has at least been planned and funded. Human suffering aside, such a hit to productivity would surely raise alarm bells across the political spectrum!

I say this solemnly: yeah… nah.

Almost five years into the pandemic, not only are there still no treatments for long Covid, there also aren’t even any diagnostic tools – and we don’t seem overly interested in finding them.

At present, a long Covid diagnosis relies on a patient finding a doctor with up-to-date knowledge, who will believe their symptoms, and who will spend time investigating further to rule out other possibilities. This mythical trifecta is out of reach for most people, particularly women, who are affected by immune conditions at far higher rates, but have their symptoms written off as hysteria; and Māori and Pasifika, who face barriers to healthcare, and have their symptoms written off as laziness. Obtaining accurate data on prevalence under these circumstances is simply impossible.

In this way, and several others, long Covid mirrors ME/CFS (myalgic encephalomyelitis), a brutally debilitating biophysical condition, though the oft misused term “chronic fatigue” doesn’t quite convey that. Around half of long Covid sufferers meet the criteria for ME/CFS, which by the World Health Organization’s scale has a worse disease burden than HIV/Aids, multiple sclerosis (MS), and many forms of cancer. But again, there are no treatments.

I suffer from ME/CFS myself. My illness predates Covid-19 and came on after an infection with cytomegalovirus (CMV). I went from a fit and active young man to debilitatingly sick and fatigued, with several unexplained symptoms.

Pre-pandemic there was estimated to be more than 25,000 people in New Zealand suffering from ME/CFS, and only one specialist in the country, working one day a week, who has since retired (well earned, bless her). For years I had been praying for any sort of diagnosis, even if it was bad, so that I could get on the path to recovery. I got the diagnosis – but for a disease with no path to recovery.

As the pandemic unfolded, patients and advocates in the ME/CFS community warned that a tsunami of disability was approaching. They were of course ignored, as they have been for decades, and are now joined by masses of long Covid sufferers facing the reality that the medical profession has no answers for them, except perhaps euthanasia.

Image: Tina Tiller

Frustrated with my lack of options, I connected with cellular immunologist Dr Anna Brooks, who had become a leading expert on long Covid, so I assumed that her biomedical research would be well supported. Alas, she detailed the uphill grind that it’s been to gain traction compared to other countries, and that generous donations, usually from patients themselves, had been the driving force of funding.

Together we founded DysImmune Research Aotearoa, with the goal of developing diagnostic tools leading to treatment for post-viral illnesses like long Covid and ME/CFS. In layman’s terms, we collect blood samples, analyse differences in cells, and put together an immune profile. My priority is ensuring that Māori and Pasifika patients and researchers are at the table and taking action into our own hands.

We’ve made a small start, and we have some incredible collaborations lined up, with far-reaching implications for community health. We’re in the process of seeking partnerships to take things forward. The expertise exists, it’s here in New Zealand. Still, the barrier to progress across the research space is the urgency for resourcing. It is dire to say the least.

Without some long-term project certainty, it’s difficult to pull the necessary teams together. While study after study illuminates more horrifying long-term effects of Covid infections, and prevention has been completely abandoned, research and development for treatments for long Covid is tanking. The private sector is at the whim of the quarterly financial report, and with no guaranteed short-term profit in treating us, it has very little incentive to take the risk.

So, barring some philanthropic miracle, only government can fill this gap. Yet where Australia had set aside A$50m specifically for long Covid research, and the US Senate considers a billion-dollar long Covid “moonshot” bill, New Zealand has allocated nothing. We’re fast asleep at the wheel. No other country can determine how many of our people are impacted by post-viral illnesses. No other country can address our specific needs.

Since this government is focused on ambition, productivity and fast-tracking, I assume they’d want to be world leaders in research, warp-speed some projects, and get long Covid sufferers back into work, no? This is what we are calling for. Not surveys. Not “talk” therapy and positive thinking. Biomedical research.

Put the money down and commit to this. Seize this opportunity to right decades of neglect. There are tens of thousands of us fighting for our lives, and millions more around the world. You think it won’t be you, then after your next inevitable Covid-19 reinfection, it is, and you’re left to wonder why nobody stepped up.

Government, iwi and whānau ora groups, health organisations, philanthropists – reach out. Let’s work.

Rohan Botica (Te Ātihaunui-a-Pāpārangi, Ngāti Tūwharetoa) is a lived-experience researcher and co-founder of DysImmune Research Aotearoa.